American College of Rheumatology
ACR on Air
As the official podcast of the American College of Rheumatology (ACR), ACR on Air seeks to have informative and engaging conversations rheumatology professionals want to hear – ranging in topic from trends in clinical practice, to issues affecting rheumatology professionals, and the changing landscape of the rheumatology field. Tune in twice a month for engaging interviews and commentary.
Be sure to visit the podcast's website and support the creator: www.rheumatology.org
Author
American College of Rheumatology
Category
Podcast website
Latest episode
Nov 17, 2026
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Episodes
Clinical Impact of "Post Approval Pregnancy Safety Studies" 17.11.2026 34:16
In this episode, we welcome rheumatologist Dr. Lisa R. Sammaritano to discuss the FDA guidance, Postapproval Pregnancy Safety Studies . We explore what current evidence tells us about medication safety during pregnancy, the challenges of distinguishing drug effects from disease-related risks, and how to interpret findings from small pregnancy registries. We also discuss underreported pregnancy out...
AI Development in Clinical Care: Promises and Pitfalls 09.11.2026 40:43
AI is already transforming medicine, but does that mean every new capability will translate into better patient care? As ACR Convergence 2026 continues this week, we spotlight Dr. Mujeeb Basit's talk, "AI Development in Clinical Care: Promises and Pitfalls," which took place Saturday, November 7. In this episode, we explore what it takes to integrate AI into clinical practice safely, effectively,...
Thriving at Every Stage: The Power of Lifestyle Medicine 08.11.2026 45:06
Our coverage of ACR Convergence 2026 continues with a conversation about moving beyond "Treat to Target" toward "Treat to Thrive." While measuring disease activity, adjusting medications, and aiming for remission are essential parts of rheumatoid arthritis care, what happens when inflammation is under control but patients still don't feel well? In this episode, we explore why controlling inflammat...
Dysfunction Mitochondria in Myositis-Driven Inflammation 07.11.2026 37:44
As part of our special coverage of ACR Convergence 2026, we're joined by Christian Lood from the University of Washington to explore a surprising role mitochondrion may play in myositis. Long known as the powerhouse of the cell, mitochondria may do more than simply respond to inflammation. When damaged, they can release contents that trigger the immune system and potentially fuel inflammation. We...
Direct Specialty Clinical Care Model 03.11.2026 47:50
What is the "Direct Specialty Clinical Care Model" and is it a viable option for clinical rheumatologists in today's medical ecosphere? Dr. Diana Girnita, founder and CEO of Rheumatologists OnCall , joins us to speak on what m otivated her to pioneer this clinical approach, how she empowers her patients by putting the cost of care directly in their hands , her thoughts on the financial viability o...
ACR Convergence 2026 Preview 20.10.2026 30:28
Join us as we explore what's new and exciting at ACR Convergence, the premier gathering for rheumatology science and innovation. Dr. Gregory Gardner, Chair of the Annual Meeting Planning Committee, shares a preview of this year's meeting, including emerging treatments like cellular therapy, hands-on workshops, and the science that could change clinical practice. We discuss the sessions you won't w...
How I Evaluate Raynaud's Disease 06.10.2026 48:01
When is Raynaud's phenomenon truly a disease? Dr. Robert Spiera joins us to discuss the key clinical clues, the value of patient photos and nail fold capillary findings, and how to approach a positive ANA without a defined connective tissue disease. We review treatment options from warming strategies and medication review to calcium channel blockers, PDE-5 inhibitors, prostaglandins, and digital s...
How I Treat & Evaluate ILD 22.09.2026 48:53
Interstitial Lung Disease (ILD) is difficult to diagnose and treat. At first, the disease could look like a variety of other disorders , such as fibrosis or autoimmunity. Once a diagnosis is made, a decision on how aggressively to treat it can mean the difference between irreversible lung damage or overly impacting your patient's quality of life . We caught up with Dr. Robert Hallowell, a Pulmon...
JIA, A Family's Perspective 08.09.2026 44:02
September is Rheumatic Disease Awareness Month (RDAM), and today we're sharing the story of Deborah Talbot, an occupational therapist from the Children's Hospit al of Philadelphia and her daughter, Molly, who was diagnosed with Juvenile Idiopathic Arthritis (JIA) at the age of 12 years old. When an ankle injury turned out to be far more, Molly endured months of pain, swelling, repeated evaluations...
Can We Prevent Rheumatoid Arthritis? 25.08.2026 36:31
Rheumatoid arthritis may begin years before the first swollen joint appears, with autoantibodies circulating long before a clinical diagnosis is made. In this episode, we explore what happens during this critical preclinical phase and whether RA can be prevented before it starts. Dr. Kevin Dean, director of the Autoimmune Disease Prevention Center at the University of Colorado Anschutz, joins us t...
The 2026 Adult/Juvenile Spondyloarthritis Guidelines 11.08.2026 44:47
The new clinical guidelines for juvenile and adult axial spondyloarthritis (axSpA), developed collaboratively by the American College of Rheumatology (ACR), the Spondylitis Association of America (SAA), and the Spondyloarthritis Research and Treatment Network (SPARTAN), mark an important evolution in the management of this complex disease. In this episode, Drs. Liron Caplan and Matthew Stoll discu...
Still's Disease and Hyperinflammation 28.07.2026 51:59
In this episode, Dr. Randy Q. Cron discusses hyperinflammation and Macrophage Activation Syndrome (MAS), one of the most serious complications of Still's disease. Because MAS can mimic infection, sepsis, malignancy, or a disease flare, early recognition is critical—and treatment often must begin before every diagnostic criterion is met. We explore the clinical patterns and laboratory findings that...
Understanding Haploinsufficiency of A20 14.07.2026 43:55
What if some patients who never quite fit their diagnosis actually have an underlying genetic disorder? In this episode, we explore Haploinsufficiency of A20 (HA20), a condition first described less than a decade ago that is already reshaping our understanding of autoinflammation, autoimmunity, and immune dysregulation. How many patients in our clinics have a genetic diagnosis we've never thoug...
Chronic Inflammatory Calcium Pyrophosphate Arthritis 30.06.2026 50:06
Could chronic inflammatory calcium pyrophosphate deposition disease (CPPD) be hiding in plain sight? In this episode, we explore why CPPD may be far more common than previously recognized, how it can masquerade as conditions such as refractory inflammatory arthritis, polymyalgia rheumatica, and erosive osteoarthritis, and why it is so often overlooked in clinical practice. We discuss the growing r...
2026 ACR JIA Guidelines: What Clinicians Need to Know 16.06.2026 50:31
The 2026 ACR Guidelines for Juvenile Idiopathic Arthritis (JIA) are here, and lead author Dr. Karen Onel joins us to unpack the key updates shaping pediatric rheumatology care. From a biologics-first approach in systemic JIA to more individualized treatment pathways for non-systemic disease, the new recommendations emphasize earlier intervention, faster treatment tailoring, and risk-based decision...
Cell Therapy in Rheumatology: CAR-T vs Regulatory T Cells 02.06.2026 30:04
In the future, can autoimmune disease become curable? A groundbreaking study from Germany suggests there may be a pathway in some cases. Patients with severe, treatment-refractory lupus who received CD19 CAR-T cell therapy have remained in drug-free remission for up to five years without ongoing immunosuppression. In this episode, we discuss how these findings are shifting the conversation from...
50 Years of Pediatric Rheumatology: A Retrospective 19.05.2026 29:14
Fifty years ago, pediatric rheumatic disease was often marked by disability, limited treatment options, and low expectations for long-term outcomes. In 1976, a small group of clinicians and scientists helped launch a new understanding of immune-mediated disease in children and laid the foundation for modern pediatric rheumatology. In this episode, we explore how the field evolved from managing chr...
VEXAS Syndrome: What You Need to Know 05.05.2026 38:30
Today , we discuss a new guidance statement from the American College of Rheumatology aimed at bringing much-needed structure to the evaluation and management of patients with VEXAS. Th is episode breaks down key recommendations, including who should be tested, the best approaches to diagnostic evaluation, how to interpret bone marrow findings, and emerging strategies for treatment—offering cla...
Support for Private Practice 21.04.2026 39:51
Private rheumatology practice is contracting under multi-directional pressure: shrinking margins, escalating prior authorizations, tightening Pharmacy Benefit Managers (PBM) and payer restrictions on drug access, and instability across core revenue streams. At the same time, demand is rising, wait times are surging, and workforce shortages are intensifying—driving clinician burnout and retention c...
Pericardial Diseases in Rheumatology & Beyond 07.04.2026 50:30
Pericardial Disease is couched between two medical disciplines: Cardiology and Rheumatology, and those with these conditions visit medical professionals viewing their treatment through one lens or the other. This episode addresses the shifting reality that pericarditis and myocarditis are no longer separate silos but rather takes the broader view of inflammatory hea rt disease. We'll examin...
Current and Evolving Treatments for Myositis 24.03.2026 37:35
For years, myositis treatment has relied on broad immune suppression with drugs like steroids, methotrexate, and rituximab—but what if we could target the disease more precisely? Inflammatory myopathies are not a single condition, but a group of biologically distinct syndromes with different clinical features and immune pathways. As our understanding evolves, so does the potential for more persona...
Strategies for Workforce Retention 10.03.2026 35:49
In this episode, we discuss the growing workforce challenges in rheumatology with nurse practitioner Chris Estes. Chris shares how he entered the field, the training he received early in his career, and how he developed expertise in musculoskeletal ultrasound. The conversation explores how advanced practice providers (APPs) can help address rheumatology workforce shortages by expanding access to...
The Next Era of Gout Therapy 24.02.2026 45:47
In this episode, we explore the paradox of gout—one of the most biologically understood and treatable diseases in medicine, yet still among the most poorly controlled chronic conditions in practice. With effective therapies readily available, why do patients continue to cycle through painful flares, start and stop medications, and return to clinics and hospitals in a pattern that feels like a re...
Precision Rheumatology, APS and You 10.02.2026 39:59
In this episode, we explore Antiphospholipid Syndrome (APS) with Dr. Yu (Ray) Zuo, beginning with a clear, clinically grounded explanation before diving into the personal and scientific journey that drew him to this notoriously complex disease. Along the way, Dr. Zuo shares a case that forever changed how he understands APS, then takes us inside his latest Arthritis & Rheumatology study, where...
The Year Ahead for The ACR with Dr. Will Harvey 27.01.2026 37:15
In this episode, we sit down with Dr. William Harvey, the newly appointed President of the American College of Rheumatology and a dedicated volunteer of nearly 20 years. Dr. Harvey shares what it's like stepping into the presidency, the key priorities shaping the year ahead, and how the ACR is approaching strategy, advocacy, partnerships, and leadership during this pivotal moment for the field...
Similar podcasts
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.